All News | FDA

Advertising & Promotion

Jan 16, 2026
OPDP Issues Untitled Letters for Branded Backgrounds, Webpages and DTC TV Ad
Dec 27, 2025
OPDP Contends Clinical Trial Results Don’t Support Cobenfy DTC TV Ad Claims
Dec 15, 2025
FDA Posts One More Untitled Letter From September DTC Ad Blitz
Dec 10, 2025
FDA Final Guidance on Promotion of Biosimilars Adds Comparison Considerations
Dec 4, 2025
OPDP Sends Untitled Letter for DTC Testimonial Video
Nov 21, 2025
Study Finds Influencers’ Drug Social Media Posts Lack Risk Info and Disclosures
Nov 19, 2025
OPDP Posts Three Untitled Letters
Nov 11, 2025
New York Assembly Considers Gift Disclosure Bill
Oct 27, 2025
Other Trump Administration Goals May Hamper DTC Enforcement
Oct 17, 2025
CDER Posts Another 11 Untitled Letters

Good Clinical Practice

Dec 23, 2025
Newly Finalized Guidance Offers Insights on BIMO Inspections Not Provided in Agency Guides, Manuals
Dec 19, 2025
FDA Revises Guidances on Safety Reporting
Dec 10, 2025
First NACHRP Guidance To Focus on IRB Flexibility for Minimal Risk Research
Dec 3, 2025
IFPMA Proposes Regulatory Reliance for Multiregional Trial Review
Nov 19, 2025
Sponsor-Investigator Receives Warning Letter After Allegedly Failing To Submit IND for Trial
Nov 5, 2025
Reagan-Udall Foundation Roundtable Develops Recommendations for Oncology MRCTs
Oct 24, 2025
Final Guidance Details Waiting Period, IRB Requirements for Expanded Access
Oct 17, 2025
National Academies Report Recommends Ways To Simplify Research Regulations
Oct 10, 2025
WHO Launches Global Forum on Clinical Trials
Oct 5, 2025
Sponsor-Investigator Receives Warning Letter After Allegedly Failing To Submit IND for Trial

U.S. Food Labeling

Dec 19,2025
FDA Considers DSHEA Disclaimer Change for Dietary Supplements
Dec 12,2025
FSIS Updates Label Approval Guideline for US Origin Claims
Nov 26,2025
Researchers Examine Effect of Calorie Information in FOP Labels
Nov 7,2025
Appeals Court Remands USDA GMO Disclosure Regs
Nov 3,2025
Group Offers Non-UPF Certification Program
Oct 22,2025
Court: FD&C Act Does Not Prevent State Requirement That Supplements With Kratom Warn of Addiction
Oct 12,2025
EU Parliament Approves Stricter Definition of Meat
Sep 21,2025
Comment Period for RFI on Ultra-Processed Foods Extended to Oct. 23
Sep 9,2025
FOPL Final Rule Expected in May 2026
Aug 26,2025
CRS Report Provides Options for Congress on Food Labeling

FDA Regulation & Enforcement

Mar 5, 2026
Preemption, Inadequate Pleading Doom Patient’s Tort Suit Against Pain Management Device Manufacturer
Mar 4, 2026
Court Won’t Halt Suit Alleging Amazon Supplement Labeling Violations While FDA Ponders Reg Change
Feb 27, 2026
Clinical Investigator Receives Warning Letter Over Incorrect Dosing
Feb 27, 2026
CVM Issues First Promotion Warning Letter of 2026
Feb 25, 2026
Device Maker’s Non-Prosecution Agreement Resolves Allegations of Health Care, Securities Fraud
Feb 25, 2026
District Court Issues Injunction Against Texas Warning Label Law
Feb 20, 2026
Florida Bills Would Allow Individuals To Sue Over Vaccine Harm, If Products Are Advertised in the State
Feb 18, 2026
OIG Offers Anti-Kickback Guidelines for Direct-to-Consumer Drug Sales Through Programs Like TrumpRx
Feb 13, 2026
FDA Will Allow ‘No Artificial Colors’ Labels for Products Not Using Oil-Based Dyes
Feb 13, 2026
OPDP Sends Five Untitled Letters Over DTC TV Ads

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.